Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...

Indeed, record-breaking vaccine development played a big role in keeping the SARS-CoV-2 virus at bay. Vaccine skeptics have ...

We recently compiled a list of the 10 Stocks Lead Wednesday’s Charge, Mirror Broader Gains. In this article, we are going to ...

MRNA is found naturally in human cells ... The effort is also finding traction at the local level. A district health department outside Boise, Idaho, last year banned its health department ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against firms that kick off shortened trading week with impressive gains. The stock market kicked off the ...

Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

Researchers at the Icahn School of Medicine at Mount Sinai say they have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection ...

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge ...

If an investor was to purchase shares of MRNA stock at the current price level of $31.95/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

A lipid nanoparticle system has been developed to deliver mRNA across the blood-brain barrier via intravenous injection, overcoming a significant challenge in treating brain diseases.